JAK inhibitorsJAK inhibitorsbiologic therapiescsDMARDshydroxychloroquinemonogenic lupusrituximabintensive care interventionslupustertiary pediatric rheumatology center+1 more
…-up, hydroxychloroquine was used in 14 patients, csDMARDs in 9, JAK inhibitors in 10, and rituximab in 4. At last visit, 10 patients had chron…